30 Day Trial
30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Subscribe to see current content

DePuy Synthes Names New Leadership in JNJ Reorganization

Johnson & Johnson (JNJ) combined its orthopaedics and surgery divisions into a single Medical Device group and named new leadership, a strategic decision that thus far comes with little detail.

OEMs, FDA Take Closer Look at Mobile Medical Applications

Mobile communication devices, particularly smartphone and applications, have already changed how we handle many aspects of our lives, such as personal finance, shopping, travel and entertainment. They are also radically changing the way we think and make decisions about our healthcare.

Company Revenue 2015: Bacterin

$9.5MM, +7% 3Demin bone grafts generated >$0.4MM since late-2014 introduction New accounts coming on are primarily in spine (which comprises ~2/3 of revenue) Signed U.S. dist...

Company Revenue 2015: Implanet

€1.5MM (~US $1.8MM), -22% (International ~$915.6MM) Spine ~$0.8MM, +78% Knee + Arthroscopy ~$0.9MM, +-32%   Growth impacted by “downturn in knee activity...

U.S. Registry Offers New TJR Data

Function and Outcomes Research for Comparative Effectiveness in Total Joint Replacement or FORCE-TJR, a 4-year, $12 million project funded by the Agency for Healthcare Research and Quality, has established the most comprehensive U.S. database on total hip and knee replacement patients and outcomes. 

Page Navigation